MAPK3 and squamous cell lung carcinoma: Using PLA, we showed that TRF2 interacts with pERK1/2 in three different cancers with constitutively active ERK1/2: cutaneous squamous cell carcinomas, lung squamous cell carcinoma and cervical squamous cell carcinoma but not in their normal tissue counterparts (Figure 3B).